ID   Shef-LMS 01 w1 variant
AC   CVCL_C8VE
SY   Shef-LMS01 w1; STS 02/11 w1; Sheffield Leiomyosarcoma Cell Line 01 (w1 variant)
DR   Wikidata; Q123033483
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 27.44 hours (Note=At 54th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pelvis, hypodermis; UBERON=UBERON_0002355+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 11
ST   D21S11: 27,30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8VF ! Shef-LMS 01 ws variant
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
RX   PubMed=27560552; DOI=10.1038/bjc.2016.259; PMCID=PMC5117779;
RA   Salawu A., Fernando M., Hughes D., Reed M.W.R., Woll P.J., Greaves C.,
RA   Day C., Alhajimohammed M.A., Sisley K.;
RT   "Establishment and molecular characterisation of seven novel
RT   soft-tissue sarcoma cell lines.";
RL   Br. J. Cancer 115:1058-1068(2016).
//
RX   PubMed=29853780; DOI=10.1155/2018/3082526; PMCID=PMC5964616;
RA   Salawu A., Wright K., Al-Kathiri A., Wyld L., Reed M.W.R., Sisley K.;
RT   "Sister chromatid exchange and genomic instability in soft tissue
RT   sarcomas: potential implications for response to DNA-damaging
RT   treatments.";
RL   Sarcoma 2018:3082526.1-3082526.8(2018).
//